| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/18/2005 | US20050181427 Peptide nucleic acid probes for identifying gene sequences associated with ion transport; fish farms and breeding |
| 08/18/2005 | US20050181426 Peptide nucleic acid probes for identifying gene sequences associated with ion transport; fish farms and breeding |
| 08/18/2005 | US20050181425 Polyvalent cation-sensing receptor in atlantic salmon |
| 08/18/2005 | US20050181422 Process for high throughput screening of CpG-based immuno-agonist/antagonist |
| 08/18/2005 | US20050181420 Polypeptide that interacts with heat shock proteins |
| 08/18/2005 | US20050181419 For detection of Mycobacterium tuberculosis infection |
| 08/18/2005 | US20050181418 Using nuclear protein (AM-1) as screening tool in diagnosing metastatic cancer |
| 08/18/2005 | US20050181413 Ovarian specific nucleic acid (OSNA) for use as diagnostic and prognostic tools in treatment and prevention of urogenital cancers; genetic vaccines |
| 08/18/2005 | US20050181411 Related to the chloride channel subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 08/18/2005 | US20050181406 HNF-1alpha gene including novel single-nucleotide polymorphism, protein encoded by the HNF-1alpha gene, and polynucleotide, microarray, kit, and method for diagnosis of MODY3 |
| 08/18/2005 | US20050181402 Immunoglobulin which specifically binds serum and glucocorticoid dependent kinase for diagnosing infection, inflammatory, kidney and liver disorders |
| 08/18/2005 | US20050181401 Reagents and methods useful for detecting diseases of the prostate |
| 08/18/2005 | US20050181397 Nucleotide sequences coding sodium/bile co-transport protein for use in diagnosis, prevention and treatment of cell proliferative; pharmacogenomics |
| 08/18/2005 | US20050181391 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 08/18/2005 | US20050181388 Novel purified polypeptides from bacteria |
| 08/18/2005 | US20050181372 Interleukin 17 receptor-like protein |
| 08/18/2005 | US20050181371 Expression vector comprising nucleotide sequences coding tyrosine kinase binding protrein for use in identifying modulator for prevention and treatment of muscular and respiratory disorders |
| 08/18/2005 | US20050181370 Using non-testis tumor markers to diagnose/prognose cell proliferative disorders; monitoring efficacy of antitumor treatments |
| 08/18/2005 | US20050181369 Compositions and methods for diagnostics and therapeutics for hydrocephalus |
| 08/18/2005 | US20050181365 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/18/2005 | US20050181362 Aligning the test nuclear receptor (NR) polypeptide, with at least one reference NR polypeptide sequence for which an X-ray structure is available; building a three-dimensional model for the test NR polypeptide, examining the three-dimensional model of the test NR polypeptide sequence for difference |
| 08/18/2005 | US20050181359 Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
| 08/18/2005 | US20050181358 Soluble complex comprising a retroviral surface glycoprotein |
| 08/18/2005 | US20050181356 Hepatitis c virus assay systems |
| 08/18/2005 | US20050181355 Compositions and methods for the modulation of viral maturation |
| 08/18/2005 | US20050181064 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith |
| 08/18/2005 | US20050181037 Cardiolipin compositions their methods of preparation and use |
| 08/18/2005 | US20050180993 Assays for the identification of compounds that inhibit assembly of nucleoprotein (NP), virion-associated proteins VP35, and VP24, or inhibit the glycosylation of NP, required for nucleocapsid formation, for use as anti-viral agents |
| 08/18/2005 | US20050180987 Method of separating protective components of bordetella pertussis |
| 08/18/2005 | US20050180984 Modulating vaccine against HIV-1 Nef protein induced lymphocyte depletion |
| 08/18/2005 | US20050180983 Antibody vaccine conjugates and uses therefor |
| 08/18/2005 | US20050180982 Assessing metastatic potential of carcinoma cells by contacting cells in tissue sample suspected of containing carcinoma with detectable indicator capable of binding to cad-11 or cad-11 mRNA and determining presence or absence of cad-11 expression in tissue; method of preventing or terminating pregnancy |
| 08/18/2005 | US20050180980 Novel antibody recognizing a small subset of human hematopoietic cells |
| 08/18/2005 | US20050180978 Isolated monoclonal antibody mAb PAB-1, deposited at ATCC on 24 Jan. 2002 and accorded accession PTA-4005, which binds to a surface antigen on nematode L3; use in preventing or treating animal nematode infections |
| 08/18/2005 | US20050180976 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases |
| 08/18/2005 | US20050180973 TREM-1 splice variant for use in modifying immune responses |
| 08/18/2005 | US20050180963 Probiotic propionibacterium |
| 08/18/2005 | US20050180950 Chemically modified TNF-alpha |
| 08/18/2005 | US20050180949 hC1Q/TNF7 and uses thereof |
| 08/18/2005 | US20050180948 Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders |
| 08/18/2005 | US20050180928 peptide having a specific amino acid sequence suppresses initial adhesion of intraoral bacteria to teeth and periodontal tissue and prevents formation of a biofilm in an oral cavity. |
| 08/18/2005 | EP1572729A3 Mutant protein and refolding method |
| 08/18/2005 | DE102004004043A1 Reinigung von hochmolekularen Verbindungen mittels Affinitätsmembranchromatographie Purification of high molecular weight compounds by means of affinity membrane chromatography |
| 08/18/2005 | CA2585231A1 Self-assembling split-fluorescent protein systems |
| 08/18/2005 | CA2556259A1 Therapeutic molecules and methods for generating and/or selecting same |
| 08/18/2005 | CA2555783A1 Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies |
| 08/18/2005 | CA2555684A1 Crystal structures and models for fc receptors and uses thereof in the design or identification of fc receptor modulator compounds |
| 08/18/2005 | CA2555469A1 Use of relaxin-3 for promoting food intake, increasing body weight gain, increasing fat weight and for others |
| 08/18/2005 | CA2555463A1 Inhibitors of tgf-r signaling for treatment of cns disorders |
| 08/18/2005 | CA2555083A1 Genes associated with canine osteoarthritis and related methods and compositions |
| 08/18/2005 | CA2555018A1 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists |
| 08/18/2005 | CA2554822A1 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation |
| 08/18/2005 | CA2554784A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 08/18/2005 | CA2554644A1 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 08/18/2005 | CA2554634A1 Compositions, methods and uses for a novel family of peptides |
| 08/18/2005 | CA2554628A1 Methods of modulating cd200 and cd200r |
| 08/18/2005 | CA2554526A1 Variants of the extracellular domain of bcma and uses thereof |
| 08/18/2005 | CA2553040A1 Modified human four helical bundle polypeptides and their uses |
| 08/18/2005 | CA2553035A1 Modified human growth hormone polypeptides and their uses |
| 08/18/2005 | CA2553034A1 Modified human interferon polypeptides and their uses |
| 08/18/2005 | CA2542291A1 Method for separating/refining cationic protein |
| 08/17/2005 | EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease |
| 08/17/2005 | EP1564287A1 Method of predicting genetic risk for hypertension |
| 08/17/2005 | EP1564286A1 Hybrid proteins of beta-lactamase class A |
| 08/17/2005 | EP1564236A1 Modified biological substance, process for producing the same, and intermediate |
| 08/17/2005 | EP1564219A1 N-terminally monopegylated polypeptides and process for their preparation |
| 08/17/2005 | EP1564218A1 Composition for oral cavity |
| 08/17/2005 | EP1563844A2 Wound healing formulations containing human plasma fibronectin |
| 08/17/2005 | EP1563843A1 Botulinum toxins for treating various disorders and associated pain |
| 08/17/2005 | EP1563834A1 Hollow nanoparticles of protein and drug using the same |
| 08/17/2005 | EP1563309A2 Use of nuclear hormone receptors to identify meiosis regulating compounds |
| 08/17/2005 | EP1563308A2 Methods and kits for diagnosing tumorigenicity |
| 08/17/2005 | EP1563298A2 Methods of isolation of active compounds and activated targets |
| 08/17/2005 | EP1563094A2 Modulators of angiogenesis and tumorigenesis |
| 08/17/2005 | EP1563075A1 Plasmids expressing human insulin and the preparation method for human insuling thereby |
| 08/17/2005 | EP1563074A2 Adenoviral vector vaccine |
| 08/17/2005 | EP1563073A2 Protein production methods and modified cells for use therein |
| 08/17/2005 | EP1563072A2 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 08/17/2005 | EP1563071A2 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 08/17/2005 | EP1563068A2 Genetic products differentially expressed in tumors and the use thereof |
| 08/17/2005 | EP1563061A1 Cultivation of hair inductive cells |
| 08/17/2005 | EP1563056A2 Composition and method for treating lupus nephritis |
| 08/17/2005 | EP1562991A2 A method for the crystallization of human serum albumin |
| 08/17/2005 | EP1562988A2 Alpha macroglobulin family member |
| 08/17/2005 | EP1562987A2 Use of edg2 receptor in an animal model of heart failure |
| 08/17/2005 | EP1562986A2 Compounds and methods for modulating functions of classical cadherins |
| 08/17/2005 | EP1562985A2 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 08/17/2005 | EP1562982A2 Unexpected surface proteins in neisseria meningitidis |
| 08/17/2005 | EP1562980A2 Nuclear factor of activated t cells receptor |
| 08/17/2005 | EP1562978A2 Rapid induction of alzheimer s amyloid plaque formation by sulfated glycosaminoglycans |
| 08/17/2005 | EP1562973A2 Susceptibility gene for myocardial infarction |
| 08/17/2005 | EP1562969A2 Novel human cell surface protein with immunoglobulin folds, bgs-19 |
| 08/17/2005 | EP1562967A2 Adipocyte complement related protein zacrp14 |
| 08/17/2005 | EP1562906A2 Heterocyclic selective androgen receptor modulators and methods of use thereof |
| 08/17/2005 | EP1562635A2 Modified dendritic cells |
| 08/17/2005 | EP1562634A1 Positional isomers of peg ifn alpha 2a |
| 08/17/2005 | EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses |
| 08/17/2005 | EP1562631A1 Bowman-birk inhibitor concentrate product and process |
| 08/17/2005 | EP1562624A2 Orally administered peptides synergize statin activity |
| 08/17/2005 | EP1562622A2 Immunogenic epitopes for fibroblast growth factor 5 (fgf-5) presented by hla-a3 and hla-a2 |